Daniel Rubin, Ph. D. is currently the Sr. Director of R&D Portfolio Strategy and Analytics at Gilead Sciences, a position held since 2023. Previously, Daniel served as Associate Director of Pipeline Insights in the Portfolio Strategy Group at Takeda from 2018 to 2019, and held various roles within Gilead Sciences between 2021 and 2023. With extensive experience in biotech and pharmaceuticals, Daniel has specialized in portfolio and life-cycle management, as well as business development strategies. Daniel earned a Ph.D. in Bioengineering from Harvard University, complementing their earlier studies with a Master's degree from UC Santa Barbara.
This person is not in the org chart
This person is not in any teams
This person is not in any offices